LYPLAL1 and metabolic dysfunction-associated steatotic liver disease: Previous studies also identified other NAFLD variants such as the Lipin-1 (LPIN1) rs13412852 [166], interleukin 27 (IL27) rs4788084 [72], GATA zinc finger domain containing 2A (GATAD2A) rs4808199 [74], lysophospholipase-like 1 (LYPLAL1) rs12137855 [39,101], angiotensin II receptor type 1 (ATGR1) rs2276736, rs3772630, and rs3772627, phosphatidylethanolamine N-methyltransferase (PEMT) rs7946 V175M [167,168,169,170,171], replication initiator 1 (REPIN1) 12-bp deletion [177], and parvin beta (PARVB) rs5764455 [48] and rs2073080 [66,101].